Polycystic Ovary Syndrome
Conditions
Brief summary
Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%. Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.
Detailed description
The aim of this work is assessment of the level of vitamin D in female have polycystic ovary syndrome & healthy female.and also make diagnostic criteria for patient who is in need for supplementations with vitamin D.
Interventions
DRUGVitamin D Levels measurement using chemiluminescent assay
Measurement of serum vitamin D levels
DEVICEVitamin D level assessment
Using lIAISON DEVICE
Sponsors
Al-Azhar University
Ghamra Military Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Intervention model description
Parallel study
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
* Hyperandrogenism * Polycystic ovary syndrome
Exclusion criteria
* Thyroid disease * Parathyroid disease * Diabetes Mellitus * Cushing syndrome * Congenital adrenal hyperplasia * Hyperprolactinemia * Renal, liver or chronic disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Levels of vitamin D in Polycystic ovary syndrome | 1 year | vitamin D levels is assumed to be significantly decreased |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Levels of vitamin D in fertile women | 1 year | vitamin D level is expected to be normal |
Countries
Egypt
Outcome results
None listed